CHEK1 and cancer: When cell cycle progression is decelerated by the inhibition or depletion of CHK1, pre-depletion of mitochondria, or the knockdown of PGC-1α, so that M arrest cannot be established, mitochondrial oxidative stress and the associated genotoxic effect caused by the cancer drugs are greatly alleviated.